is there a patent on semaglutide HOLVES丨The for has expired A Snapshot of the Semaglutide

GLP-1-RAs, known for their antidiabetic effects, may reduce this risk by improving metabolic health and inhibiting cancer cell proliferation

For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease

The combined effect of enhancing insulin sensitivity and reducing inflammatory markers positions omega-3 fatty acids as an attractive intervention for metabolic disorders associated with NAFLD

F., Lian T.F., 1996